These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11959224)

  • 1. Predictive value of cyclosporine blood levels during the absorption phase to estimate the area under the curve in stable renal transplant patients.
    Sabaté I; Calzada P; Gil-Vernet S; Fulladosa X; Baró S; González C; Castro MJ; Castelao AM; Grinyó JM
    Transplant Proc; 2002 Feb; 34(1):140-1. PubMed ID: 11959224
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant.
    Yang WC; Chen YF; King KL; Wu TH; Chen Hsu RY ; Tang JJ; Loong CC; Chou MH; Lin MF; Lui WY
    Transplant Proc; 2000 Nov; 32(7):1685-7. PubMed ID: 11119892
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine peak concentration in relation to the four-hour absorption phase in pediatric renal graft recipients.
    Wigger M; Drückler E; Muscheites J; Stolpe HJ; Kundt G; Wacke R
    Transplant Proc; 2001; 33(7-8):3126-7. PubMed ID: 11750344
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine absorption profiling and therapeutic drug monitoring using C(2) blood levels in stable renal allograft recipients.
    Einecke G; Mai I; Diekmann F; Fritsche L; Neumayer HH; Budde K
    Transplant Proc; 2002 Aug; 34(5):1738-9. PubMed ID: 12176557
    [No Abstract]   [Full Text] [Related]  

  • 5. Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant.
    Rial MC; Frias S; Argento J; Tessler J; Casadei D
    Transplant Proc; 1997; 29(1-2):292-3. PubMed ID: 9123001
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of abbreviated AUC of cyclosporine in renal allograft recipients in a Pakistani population.
    Zafar MN; Abbas K; Naqvi A; Rizvi A
    Transplant Proc; 1999 Dec; 31(8):3304. PubMed ID: 10616486
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of cyclosporine absorption profiles over a 12-month period in stable pediatric renal transplant recipients.
    Wigger M; Drückler E; Muscheites J; Stolpe HJ; Kundt G; Wacke R
    Transplant Proc; 2003 Jun; 35(4):1300-3. PubMed ID: 12826143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients.
    Citterio F; Scatà MC; Borzi MT; Pozzetto U; Castagneto M
    Transplant Proc; 2001; 33(7-8):3133-6. PubMed ID: 11750347
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimated area-under-the-curve monitoring of Neoral in a stable pediatric renal transplant population: one-year experience.
    Lemire J; Capparelli EV; MacDonald D; Benador N; Reznik VM; Mendoza SA; Griswold WR
    Transplant Proc; 1998 Aug; 30(5):1983-4. PubMed ID: 9723361
    [No Abstract]   [Full Text] [Related]  

  • 10. Sandimmun and Neoral treatment: pharmacokinetics and kidney function in paediatric and adolescent renal transplant.
    De Palma MT; Giordano M; Colella V; Palumbo F; De Nicolo VE; Caringella DA
    Transplant Proc; 1998 Aug; 30(5):1677. PubMed ID: 9723239
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C(0)) and C(2) concentrations in stable renal allograft recipients.
    Einecke G; Mai I; Diekmann F; Fritsche L; Boehler T; Neumayer HH; Budde K
    Transplant Proc; 2001; 33(7-8):3102-3. PubMed ID: 11750333
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic study of twice vs thrice daily dosing of Sandimmun Neoral in pediatric renal transplant patients.
    Papachristou F; Gakis D; Sotiriou I; Liatsis I; Takoudas D; Antoniadis A
    Transplant Proc; 1998 Aug; 30(5):1988-90. PubMed ID: 9723363
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine Neoral profiling in Japanese renal transplant recipients.
    Aikawa A; Arai K; Tajima E; Kawamura T; Ogiwara H; Sakai K; Mizuiri S; Ohara T; Hasegawa A; Kosugi T; Kusano A; Matsuo K; Obayashi M; Kurokawa M
    Transplant Proc; 2001; 33(7-8):3142-5. PubMed ID: 11750350
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of different sampling times for best prediction of cyclosporine area under the curve in renal transplant recipients.
    Sud K; Singh B; Kohli HS; Jha V; Gupta KL; Sakhuja V
    Transplant Proc; 2002 Dec; 34(8):3168-70. PubMed ID: 12493408
    [No Abstract]   [Full Text] [Related]  

  • 15. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
    Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
    Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of Sandimmune pharmacokinetics in renal transplant patients.
    Wingerchuk C; Heim-Duthoy KL; Macres MG; Kasiske BL
    Transplant Proc; 1998 Aug; 30(5):1656-7. PubMed ID: 9723230
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine trough levels in diabetic and nondiabetic renal transplant patients.
    Wadhawan S; Jauhari H; Singh S
    Transplant Proc; 2000 Nov; 32(7):1683-4. PubMed ID: 11119891
    [No Abstract]   [Full Text] [Related]  

  • 18. C2 monitoring and absorption profiling of cyclosporine for optimization of immunosuppressive therapy in pediatric renal transplant recipients.
    Weber LT; Shipkova M; Armstrong VW; Mehls O; Oellerich M; Tönshoff B;
    Transplant Proc; 2003 Sep; 35(6):2128-30. PubMed ID: 14529863
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function.
    Konstadinidou I; Boletis JN
    Transplant Proc; 2004 Mar; 36(2 Suppl):163S-166S. PubMed ID: 15041329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of two-point AUC(0-4) monitoring in maintenance renal transplant patients.
    Uchida K; Tominaga Y; Haba T; Katayama A; Sato T; Matsuoka S; Goto N; Kimata T; Takeda A; Morozumi K; Takagi H; Kobayashi T; Yokoyama I; Nakao A
    Transplant Proc; 2001; 33(7-8):3128-30. PubMed ID: 11750345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.